{"id":"NCT02942004","sponsor":"Sage Therapeutics","briefTitle":"A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-08-01","primaryCompletion":"2017-09-24","completion":"2017-10-19","firstPosted":"2016-10-21","resultsPosted":"2019-06-13","lastUpdate":"2022-01-28"},"enrollment":138,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Postpartum Depression"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"SAGE-547 60 μg/kg/h","otherNames":[]},{"type":"DRUG","name":"SAGE-547 90 μg/kg/h","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"SAGE-547 60 μg/kg/h","type":"EXPERIMENTAL"},{"label":"SAGE-547 90 μg/kg/h","type":"EXPERIMENTAL"}],"summary":"The purpose of this study was to determine if SAGE-547 Injection infused intravenously at up to 90 micrograms per kilogram per hour (μg/kg/h) for 60 hours reduces depressive symptoms in participants with severe postpartum depression (PPD) compared to placebo injection as assessed by the change from baseline in Hamilton Rating Scale for Depression (HAM-D) total score.","primaryOutcome":{"measure":"Change From Baseline at 60 Hours in the 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score","timeFrame":"Baseline, Hour 60","effectByArm":[{"arm":"Placebo","deltaMin":-14.04,"sd":1.148},{"arm":"SAGE-547 60 μg/kg/h","deltaMin":-19.54,"sd":1.231},{"arm":"SAGE-547 90 μg/kg/h","deltaMin":-17.72,"sd":1.193}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0013"},{"comp":"OG000 vs OG002","p":"0.0252"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":32,"countries":["United States"]},"refs":{"pmids":["33181049","30177236"],"seeAlso":["http://www.sagerx.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":43},"commonTop":["Headache","Dizziness","Somnolence","Infusion site pain","Dry mouth"]}}